Stocks & Investing
Thu, August 15, 2024 John Lee Maintained (ANAB) at Hold with Increased Target to $30 on, Aug 15th, 2024
John Lee of Truist Securities, Maintained "AnaptysBio, Inc." (ANAB) at Hold with Increased Target from $20 to $30 on, Aug 15th, 2024.
John has made no other calls on ANAB in the last 4 months.
There are 4 other peers that have a rating on ANAB. Out of the 4 peers that are also analyzing ANAB, 0 agree with John's Rating of Hold.
These are the ratings of the 4 analyists that currently disagree with John
- Emily Bodnar of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $55 on, Wednesday, August 14th, 2024
- Anupam Rama of "JP Morgan" Maintained at Buy with Increased Target to $75 on, Wednesday, August 7th, 2024
- David Nierengarten of "Wedbush" Reiterated at Buy and Held Target at $34 on, Friday, May 10th, 2024
- David Risinger of "Leerink Partners" Initiated at Buy and Held Target at $47 on, Tuesday, April 16th, 2024
